Don’t be tempted to buy on these headline-driven stock-market dips, bigger opportunities are coming, says Truist’s Keith Lerner.

Novo Nordisk stock gained, lifted by strong sales growth and guidance from the maker of Wegovy and Ozempic. Shares in Novo, one of Europe's largest listed companies, advanced nearly 3% in Denmark. Dig ...